¼¼°èÀÇ »óó Ä¡·á¸¦ À§ÇÑ Á¶Á÷°øÇÐ ½ÃÀå º¸°í¼­(2025³â)
Tissue Engineering For Wound Care Global Market Report 2025
»óǰÄÚµå : 1760726
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,192,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 8,951,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,709,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

»óó Ä¡·á¸¦ À§ÇÑ Á¶Á÷°øÇÐ ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È ¿¬Æò±Õ 14.8%ÀÇ ¼ºÀå·ü(CAGR)·Î 2029³â±îÁö 121¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¼ºÀåÀº ȯÀÚÀÇ »óó °ü¸®¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ¼ö¼ú °Ç¼ö ¹× ¼ö¼ú °ü·Ã »óó Áõ°¡, ´ç´¢º´ ¹× °ü·Ã ÇÕº´Áõ ¹ß»ý·ü Áõ°¡, ÇǺΠÀÌ½Ä ¹× Àç»ý Ä¡·á °Ç¼ö Áõ°¡, ¿¬±¸ °³¹ß Ȱµ¿ Áõ°¡ µîÀÇ ¿äÀο¡ ±âÀÎÇÏ´Â °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÀÌ ½Ã±âÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â Á¶Á÷°øÇÐ ±â¼úÀÇ ¹ßÀü, Á¶Á÷ Àç»ýÀ» À§ÇÑ Ã·´Ü »ýüÀç·áÀÇ °¡¿ë¼º, »óó Ä¡À¯¸¦ À§ÇÑ 3D ¹ÙÀÌ¿ÀÇÁ¸°ÆÃÀÇ Çõ½Å, »ý¹°ÇÐÀû ±Ù°Å¿¡ ±â¹ÝÇÑ »óó Ä¡·á Á¦Ç°ÀÇ Ã¤Åà Ȯ´ë, Çаè¿Í »ê¾÷°è¿ÍÀÇ Çù·Â µîÀ» ²ÅÀ» ¼ö ÀÖ½À´Ï´Ù.

±Ù°ñ°Ý°è ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ÇâÈÄ ¸î ³â µ¿¾È »óó Ä¡·á¸¦ À§ÇÑ Á¶Á÷°øÇÐ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±Ù°ñ°Ý°è ÁúȯÀº ±ÙÀ°, »À, °üÀý, ÈûÁÙ ¶Ç´Â Àδ뿡 ¿µÇâÀ» ¹ÌÃÄ ÅëÁõ, »»»»ÇÔ, ¿òÁ÷ÀÓÀÇ Á¦ÇÑÀ» ÃÊ·¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÁúȯÀº ¾É¾Æ¼­ »ýȰÇÏ´Â ½Ã°£ÀÌ ±æ¾îÁü¿¡ µû¶ó Á¡Á¡ ´õ ÈçÇØÁö°í ÀÖÀ¸¸ç, Àå½Ã°£ ¾É¾Æ Àְųª ¿îµ¿·®ÀÌ °¨¼ÒÇÏ¸é ±ÙÀ°ÀÌ ¾àÇØÁö°í °üÀý¿¡ ºÎ´ãÀ» ÁÖ¾î Àå±âÀûÀÎ °Ç°­ ¹®Á¦¸¦ À¯¹ßÇÒ ¼ö ÀÖ½À´Ï´Ù. »óó Ä¡·á¸¦ À§ÇÑ Á¶Á÷°øÇÐÀº ¼Õ»óµÈ Á¶Á÷ÀÇ Àç»ýÀ» ÃËÁøÇϰí ÀÚ¿¬ Ä¡À¯°¡ ºÒÃæºÐÇÑ ºÎÀ§ÀÇ ±â´É ¹× ±¸Á¶ ȸº¹À» µµ¿Í ±Ù°ñ°Ý°è Àå¾Ö¿¡ ´ëóÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 3¿ù Office for Health Improvement and Disparities°¡ ¹ßÇ¥ÇÑ º¸°í¼­¿¡ µû¸£¸é, ¿µ±¹¿¡¼­ 16¼¼ ÀÌ»ó °³ÀÎÀÇ 17.6%°¡ 2022³â¿¡ Àå±âÀûÀÎ ±Ù°ñ°Ý°è Áõ»óÀ» ÀÚ°¢Çϰí ÀÖÀ¸¸ç, ÀÌ´Â 2021³âÀÇ 17.0%¿¡¼­ Áõ°¡ÇÑ ¼öÄ¡ÀÔ´Ï´Ù. Áõ°¡Çß½À´Ï´Ù. °á°úÀûÀ¸·Î ±Ù°ñ°Ý°è ÁúȯÀÇ À¯º´·ü Áõ°¡´Â »óó Ä¡·á¸¦ À§ÇÑ Á¶Á÷°øÇÐ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼ö¼ú Áß 3D ÇÁ¸°ÆÃÀÇ °³¹ßÀº °³ÀÎ ¸ÂÃãÇü »óó Ä¡·á¿¡ Çõ¸íÀ» °¡Á®¿Ô°í, »óó Ä¡·á¸¦ À§ÇÑ Á¶Á÷°øÇÐ ½ÃÀåÀÇ ±â¾÷µéÀº Çõ½ÅÀûÀÎ ¼Ö·ç¼Ç °³¹ß¿¡ ÁýÁßÇϰí ÀÖ½À´Ï´Ù. ¼ö¼ú Áß 3D ÇÁ¸°ÅÍ´Â ¼ö¼ú Áß ¸ÂÃãÇü ÀÓÇöõÆ®, ¸ðµ¨, µµ±¸¸¦ ½Ç½Ã°£À¸·Î Á¦ÀÛÇÏ¿© Á¤È®µµ¸¦ ³ôÀ̰í ȯÀÚ ¸ÂÃãÇü Ä¡·á¸¦ °¡´ÉÇÏ°Ô Çϴ ÷´Ü ÀåÄ¡ÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹¿¡ º»»ç¸¦ µÐ »ý¸í°øÇÐ ±â¾÷ ŸÀÌµå ¸ÞµðÄÃ(Tides Medical)Àº 2024³â 9¿ù °³ÀÎ ¸ÂÃãÇü »óó Ä¡·á ¼ö¼ú Áß 3D ÇÁ¸°ÅÍ APLICOR 3D¸¦ Ãâ½ÃÇß½À´Ï´Ù. ÀÌ ±â¼úÀº ȯÀÚ ÀÚ½ÅÀÇ Á¶Á÷, ÀΰøÁö´É, 3D ÇÁ¸°Å͸¦ »ç¿ëÇÏ¿© Ä¡·á ºÎÀ§¿¡ Á÷Á¢ °³ÀÎÈ­µÈ ÇǺΠÀÌ½ÄÆíÀ» ¸¸µé¾î »óó Ä¡·á¸¦ Çõ½ÅÀûÀ¸·Î º¯È­½Ãŵ´Ï´Ù. ÀÌ ÇÁ·Î¼¼½º´Â °ø±Þ¸Á ¹°·ù¸¦ °£¼ÒÈ­Çϰí Àç°íÀÇ Çʿ伺À» ÁÙÀ̸ç ÀÇ»çÀÇ ¾÷¹« ºÎ´ãÀ» ÁÙ¿©ÁÖ´Â °£¼ÒÈ­µÈ ÇÁ·Î¼¼½ºÀÔ´Ï´Ù. Àü¿ë ÅÂºí¸´À¸·Î »óó¸¦ ½ºÄµÇϰí Á¤È®ÇÑ Å©±â, ±íÀÌ, Á¶Á÷·®À» °áÁ¤ÇÑ ÈÄ 3D ÆÄÀÏÀ» ÇÁ¸°ÅÍ·Î Àü¼ÛÇÕ´Ï´Ù. ÀÌÈÄ ÇÁ¸°ÅÍ´Â °¡°øµÈ Áö¹æÀ¸·Î ¸¸µç ¹ÙÀÌ¿À À×Å©¸¦ »ç¿ëÇÏ¿© ÀÌ½ÄÆíÀ» Á¦ÀÛÇÏ¿© 1½Ã°£ À̳»¿¡ È¿°úÀûÀÎ »óó ºÀÇÕÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ª ÀüÀï°ú °ü¼¼, ±×¸®°í ÄڷγªÀç³­°ú ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Tissue engineering for wound care is a specialized area that focuses on enhancing the natural repair and regeneration of damaged tissue by combining biological components, such as cells and supportive materials. The goal is to create an environment conducive to healing, promoting the growth of new tissue.

Key materials used in tissue engineering for wound care include scaffolds, tissue grafts, and other supportive materials. A scaffold is a three-dimensional structure that provides physical support to cells, allowing them to attach, proliferate, and differentiate to form new tissue. Scaffolds are used in the treatment of both chronic and acute wounds, and they are applied in skin regeneration, bone and cartilage regeneration, soft tissue repair, and organ regeneration. These products are utilized by various end-users, such as hospitals, specialty centers and clinics, and ambulatory surgical centers.

The tissue engineering for wound care market research report is one of a series of new reports from The Business Research Company that provides tissue engineering for wound care market statistics, including tissue engineering for wound care industry global market size, regional shares, competitors with a tissue engineering for wound care market share, detailed tissue engineering for wound care market segments, market trends and opportunities, and any further data you may need to thrive in the tissue engineering for wound care industry. This tissue engineering for wound care market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tissue engineering for wound care market size has grown rapidly in recent years. It will grow from $6.08 billion in 2024 to $6.99 billion in 2025 at a compound annual growth rate (CAGR) of 15.1%. The growth during the historic period can be attributed to factors such as the rising prevalence of chronic wounds, an aging population, a higher incidence of traumatic injuries from accidents and burns, supportive government initiatives and funding for wound care research, and increased healthcare expenditure.

The tissue engineering for wound care market size is expected to see rapid growth in the next few years. It will grow to $12.15 billion in 2029 at a compound annual growth rate (CAGR) of 14.8%. The growth during the forecast period can be attributed to factors such as rising awareness of wound care management among patients, an increasing number of surgeries and surgery-related wounds, a high incidence of diabetes and related complications, a rise in the number of skin grafts and regenerative treatments, and more research and development activities. Key trends during this period include advancements in tissue engineering technologies, the availability of advanced biomaterials for tissue regeneration, innovations in 3D bioprinting for wound healing, greater adoption of biologically-based wound care products, and collaborations between academic institutions and the industry.

The rising prevalence of musculoskeletal disorders is expected to drive the growth of the tissue engineering for wound care market in the coming years. Musculoskeletal disorders, which affect muscles, bones, joints, tendons, or ligaments, lead to pain, stiffness, and limited movement. These conditions are becoming more common due to increasingly sedentary lifestyles, where prolonged sitting and reduced physical activity contribute to muscle weakening and joint stress, resulting in long-term health issues. Tissue engineering for wound care plays a crucial role in addressing musculoskeletal disorders by promoting the regeneration of damaged tissues, helping restore function and structure in areas where natural healing is insufficient. For example, a report by the Office for Health Improvement and Disparities in March 2023 revealed that 17.6% of individuals aged 16 and over in the UK self-reported a long-term musculoskeletal condition in 2022, up from 17.0% in 2021. As a result, the increasing prevalence of musculoskeletal disorders is expected to drive the growth of the tissue engineering for wound care market.

Advancements in intraoperative 3D printing are revolutionizing personalized wound care, with companies in the tissue engineering for wound care market focusing on developing innovative solutions. Intraoperative 3D printers are advanced devices used during surgical procedures to create customized implants, models, or tools in real-time, improving precision and enabling patient-specific treatments. For example, in September 2024, Tides Medical, a US-based biotechnology company, launched the APLICOR 3D, a personalized wound care intraoperative 3D printer. This technology transforms wound care by using the patient's own tissue, artificial intelligence, and 3D printing to create personalized skin grafts directly at the treatment site. The process is streamlined, simplifying supply chain logistics, reducing inventory needs, and lessening physician workload. After scanning the wound with a specialized tablet to determine the precise size, depth, and tissue volume, the 3D file is sent to the printer. The printer then constructs the graft using bio-ink made from processed fat, allowing effective wound closure in under an hour.

In March 2022, Convatec Group Plc, a UK-based company specializing in medical products and technologies, acquired Triad Life Sciences Inc. for $450 million. This acquisition allows Convatec to expand its advanced wound care portfolio and enhance its position in the regenerative medicine market. The move reinforces Convatec's leadership in regenerative wound care solutions and supports the development of advanced biologically derived therapies. Triad Life Sciences Inc. is a US-based company, known for providing tissue engineering solutions for wound care.

Major players in the tissue engineering for wound care market are Zimmer Biomet Holdings Inc., Smith & Nephew plc, ConvaTec Group Plc, MTF Biologics Wound Care, StemSys Technologies Inc., MiMedx Group Inc., LIFENET HEALTH INC., Vericel, BioTissue Inc., Kerecis LLC, Aroa Biosurgery Ltd., Avita Medical, PolyNovo Limited, Tissue Regenix Group PLC, CollPlant Biotechnologies Ltd., BioStem Technologies Inc., InGeneron Inc., Applied Tissue Technologies LLC, Conexeu Sciences Inc., and WTG Biotech.

North America was the largest region in the tissue engineering for wound care market in 2024. The regions covered in tissue engineering for wound care report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the tissue engineering for wound care market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tissue engineering for wound care market consists of revenues earned by entities by providing services such as cell culture and expansion services, biomaterial research and development, and wound healing assessment and analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The tissue engineering for wound care market also includes sales of engineered skin substitutes, hydrogel dressings, bioactive wound dressings, and 3D bioprinted tissues. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tissue Engineering For Wound Care Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tissue engineering for wound care market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for tissue engineering for wound care ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tissue engineering for wound care market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Tissue Engineering For Wound Care Market Characteristics

3. Tissue Engineering For Wound Care Market Trends And Strategies

4. Tissue Engineering For Wound Care Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Tissue Engineering For Wound Care Growth Analysis And Strategic Analysis Framework

6. Tissue Engineering For Wound Care Market Segmentation

7. Tissue Engineering For Wound Care Market Regional And Country Analysis

8. Asia-Pacific Tissue Engineering For Wound Care Market

9. China Tissue Engineering For Wound Care Market

10. India Tissue Engineering For Wound Care Market

11. Japan Tissue Engineering For Wound Care Market

12. Australia Tissue Engineering For Wound Care Market

13. Indonesia Tissue Engineering For Wound Care Market

14. South Korea Tissue Engineering For Wound Care Market

15. Western Europe Tissue Engineering For Wound Care Market

16. UK Tissue Engineering For Wound Care Market

17. Germany Tissue Engineering For Wound Care Market

18. France Tissue Engineering For Wound Care Market

19. Italy Tissue Engineering For Wound Care Market

20. Spain Tissue Engineering For Wound Care Market

21. Eastern Europe Tissue Engineering For Wound Care Market

22. Russia Tissue Engineering For Wound Care Market

23. North America Tissue Engineering For Wound Care Market

24. USA Tissue Engineering For Wound Care Market

25. Canada Tissue Engineering For Wound Care Market

26. South America Tissue Engineering For Wound Care Market

27. Brazil Tissue Engineering For Wound Care Market

28. Middle East Tissue Engineering For Wound Care Market

29. Africa Tissue Engineering For Wound Care Market

30. Tissue Engineering For Wound Care Market Competitive Landscape And Company Profiles

31. Tissue Engineering For Wound Care Market Other Major And Innovative Companies

32. Global Tissue Engineering For Wound Care Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tissue Engineering For Wound Care Market

34. Recent Developments In The Tissue Engineering For Wound Care Market

35. Tissue Engineering For Wound Care Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â